Although DUOX1 was significantly downregulated in GOLD IV patients, it was not significantly reduced in patients with moderate COPD (GOLD II), which may suggest that DUOX1 status declines gradually as COPD progresses and may be a symptom of COPD pathology rather than a causative factor. The gene discussed is DUOX1; the disease is chronic obstructive pulmonary disease.